Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Peel Hunt
$196.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BTG Plc Announces Proposed Placing Of New Ordinary Shares


Thursday, 23 May 2013 02:01am EDT 

BTG Plc announced its intention to conduct a placing of up to approximately 32.8 million new ordinary shares in the Company (the Placing Shares) representing up to 9.99 per cent. of the Company's existing issued ordinary share capital (the Placing). The Placing is being conducted through an accelerated bookbuilding process (the Bookbuild) which will be launched immediately following this announcement. Deutsche Bank AG, London Branch (Deutsche Bank) and J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove (J.P. Morgan Cazenove), are acting as joint bookrunners in connection with the Placing. The net proceeds of the Placing are proposed to be used to fund part of the consideration for the Targeted Therapies Acquisition and the EKOS Acquisition, with the balance being funded through existing BTG cash resources. Following the completion of the two transactions, BTG's committed facilities and cash are expected to total approximately GBP80 million, including a GBP60 million bank facility available for general corporate purposes. The Placing has been fully underwritten by J.P. Morgan Cazenove and Deutsche Bank subject to the conditions and termination rights set out in the placing agreement between the Company, J.P. Morgan Cazenove and Deutsche Bank (the Placing Agreement). 

Company Quote

791.0
-3.5 -0.44%
30 Jan 2015